Contessa Selected by Centers for Medicare & Medicaid Services to Test Medicare Dementia Care Model
August 21 2024 - 6:30AM
Today, Contessa Health, a subsidiary of Amedisys Inc. (Nasdaq:
AMED), announced they have been selected by the Centers for
Medicare & Medicaid Services (CMS) to participate in a new
Medicare alternative payment model designed to support people
living with dementia and their caregivers. Under CMS’ Guiding an
Improved Dementia Experience (GUIDE) Model, Contessa will be one of
almost 400 participants building Dementia Care Programs (DCPs)
across the country, working to increase care coordination and
improve access to services and supports, including respite care,
for people living with dementia and their caregivers.
“CMS is excited to partner with Contessa under the GUIDE Model,”
said CMS Administrator Chiquita Brooks-LaSure. “GUIDE is a new
approach to how Medicare will pay for the care of people living
with dementia. The GUIDE participants are envisioning new ways to
support not only people living with dementia, but also to reduce
strain on the people who care for them, so that more Americans can
remain in their homes and communities, rather than in
institutions.”
Launched on July 1, 2024, the GUIDE Model will test a new
payment approach for key supportive services furnished to people
living with dementia, including: comprehensive, person-centered
assessments and care plans; care coordination; 24/7 access to an
interdisciplinary care team member or help line; and certain
respite services to support caregivers. People with dementia and
their caregivers will have the assistance and support of a Care
Navigator to help them access clinical and non-clinical services
such as meals and transportation through community-based
organizations.
“Our team of nurse practitioners, nurses, and social workers
have tremendous experience in helping patients and caregivers
navigate through the complex world of healthcare. Through the GUIDE
Model, we are able to apply this clinical model for dementia
patients and their caregivers to allow this vulnerable population
to be able to live at home longer and achieve a better quality of
life,” said Gavin Baumgardner, DO, MHA, Contessa’s Vice President
and National Medical Director of Palliative Care at Home.
Contessa’s participation in the GUIDE Model will help people
living with dementia and their caregivers have access to education
and support, such as training programs on best practices for caring
for a loved one living with dementia. The GUIDE Model also provides
respite services for certain people, enabling caregivers to take
temporary breaks from their caregiving responsibilities. Respite is
being tested under the GUIDE Model to assess its effect on helping
caregivers continue to care for their loved ones at home,
preventing or delaying the need for facility care.
GUIDE Participants represent a wide range of health care
providers, including large academic medical centers, small group
practices, community-based organizations, health systems, hospice
agencies, and other practices.
This model delivers on a promise in the Biden Administration’s
Executive Order on Increasing Access to High-Quality Care and
Supporting Caregivers and aligns with the National Plan to Address
Alzheimer’s Disease. For more information on CMS’ GUIDE Model,
please visit:
https://www.cms.gov/priorities/innovation/innovation-models/guide.
About Contessa Health:Contessa, an Amedisys
company, delivers comprehensive care at home. An industry pioneer
since 2015, Contessa provides a coordinated suite of services
including Recovery Care at Home, in lieu of being admitted to a
hospital, Rehabilitation Care at Home, in lieu of being admitted to
a skilled nursing facility, and Palliative Care at Home. Combining
all the essential elements of an inpatient hospital or
rehabilitation stay into the comfort of patients’ homes, Contessa
allows partners to reimagine care delivery. Contessa utilizes Care
Convergence™, a proprietary technology platform, to power a
seamless solution that is safe, affordable and improves patient
outcomes. Based in Nashville, the company currently partners
with 11 health systems and multiple health plans serving patients
in nine states. Contessa has the ability to serve more patients in
a full care continuum, from primary care to end-of-life, all in the
comfort of home. For more information, visit contessahealth.com or
follow us at @contessahealth.
About Amedisys: Amedisys, Inc. is a leading
healthcare at home company delivering personalized home health,
hospice and high-acuity care services. Amedisys is focused on
delivering the care that is best for our patients, whether that is
inpatient hospital, palliative, and skilled nursing facility
(“SNF”) care in their homes; home-based recovery and rehabilitation
after an operation or injury; care focused on empowering them to
manage a chronic disease; or hospice care at the end of life.
Nearly 3,000 hospitals and more than 110,000 physicians nationwide
have chosen Amedisys as a partner in post-acute care. Founded in
1982, headquartered in Baton Rouge, LA with an executive office in
Nashville, TN, Amedisys is a publicly held company. With
approximately 19,000 employees in 521 care centers in 37 states and
the District of Columbia, Amedisys is dedicated to delivering the
highest quality of care to the doorsteps of nearly 470,000 patients
in need every year, performing more than 10.6 million visits
annually. For more information about the Company, please visit:
www.amedisys.com.
Contact: |
|
Nick MuscatoAmedisys, Inc.Chief Strategy
Officer615.928.5452nick.muscato@amedisys.com |
Kendra KimmonsAmedisys, Inc.Media
Relations225.299.3720kendra.kimmons@amedisys.com |
Amedisys (NASDAQ:AMED)
Historical Stock Chart
From Nov 2024 to Dec 2024
Amedisys (NASDAQ:AMED)
Historical Stock Chart
From Dec 2023 to Dec 2024